Sharemaestro Newsreel

COMPASS Pathways Q2 2026 Loss Widens 358.5% Beyond Estimates

COMPASS Pathways plc (NASDAQ:CMPS) reported a Q2 2026 loss of $1.88 per share, significantly wider than the estimated $0.41, representing a 358.5% miss. Despite the substantial net loss of $253.8M, the stock rallied 4.9%, indicating investor focus on clinical development milestones over immediate financial …

Arrowstreet Capital Limited Partnership Acquires New Holdings in InnovAge Holding Corp. $INNV

Arrowstreet Capital Limited Partnership has acquired 417,538 shares of InnovAge Holding Corp. (NASDAQ:INNV) for approximately $3.35 million, representing about 0.31% of the company. Other institutional investors have also increased their stakes in InnovAge, though the stock has received "Sell" ratings from multiple analysts. InnovAge …

Insiders At Pediatrix Medical Group Sold US$1.8m In Stock, Alluding To Potential Weakness

This article analyzes insider selling at Pediatrix Medical Group (NYSE:MD) totaling US$1.8m over the last year, particularly a large sale by the CEO, which could signal potential weakness in the company's future performance. Despite the stock price being down 23% in the past 12 …

The Pennant Group, Inc. (PNTG) Tops Q2 Earnings and Revenue Estimates

The Pennant Group, Inc. (PNTG) reported strong Q2 earnings of $0.36 per share, surpassing the Zacks Consensus Estimate of $0.33 and outperforming the previous year's $0.27. The company also exceeded revenue expectations, posting $297.98 million against an estimated $297.98 million. Despite the positive results …

Encompass Health earnings on deck after strong start to 2026

Encompass Health (EHC) is preparing to release its second-quarter earnings, with analysts anticipating $1.48 EPS and $1.57 billion in revenue, reflecting a strong start to the year. Investors will be closely watching the company's ability to manage an ambitious capacity expansion and maintain operational …

StoneSprings Hospital CEO steps down after 2 years

Tammy Razmic has stepped down as CEO of StoneSprings Hospital after two years. This marks the sixth CEO change for the hospital in 11 years, and the chief nursing officer will serve as interim CEO during the search for a permanent replacement. The article …

HCA Healthcare Inc. stock outperforms competitors on strong trading day

HCA Healthcare Inc. (HCA) shares rose 2.22% to $409.64 on Wednesday, outperforming competitors despite a mixed trading session. The Dow Jones Industrial Average saw gains, while the S&P 500 Index declined. The company's stock closed 26.39% below its 52-week high.

DaVita Inc. stock underperforms Wednesday when compared to competitors

Shares of DaVita Inc. (DVA) plunged 17.24% on Wednesday, closing at $188.69. This underperformance occurred during a mixed trading session where the Dow Jones Industrial Average rose, but the S&P 500 Index fell. The stock experienced its third consecutive day of losses.

Barclays Adjusts Price Target on DaVita to $224 From $218

Barclays has increased its price target for DaVita Inc. (DVA) to $224 from $218. This adjustment follows other analyst updates, with BofA raising its target to $170 and Deutsche Bank to $265, reflecting varied outlooks on the healthcare facilities and services provider. The article …

PACS Group, Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:PACS) 2026-08-05

PACS Group, Inc. released its Q2 2026 earnings call presentation, reporting an EPS of $0.63, beating estimates by $0.07. The company also announced revenue of $1.43 billion, surpassing expectations by $14.12 million and showing a 9.07% year-over-year increase. This presentation provides detailed insights into …

Jefferies Remains a Sell on Fresenius Medical Care AG & Co. KGaA (0H9X)

Jefferies analyst James Vane maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA (0H9X) with a price target of €31.00. This follows similar Sell ratings from UBS and a Hold rating from Bernstein on the same day. The article notes the …

Kaplan Fox Announces an Investigation Into The Ensign Group, Inc. (NASDAQ: ENSG) for Potential Securities Law Violations

Kaplan Fox & Kilsheimer LLP has launched an investigation into The Ensign Group, Inc. (NASDAQ: ENSG) following allegations of securities law violations. A report by Hunterbrook Media accused Ensign of delivering inadequate patient care and manipulating quality data, leading to an 8.15% drop in …

COMPASS Pathways (CMPS) Is Up 8.8% After Q2 Net Loss Surges To US$254 Million – Has The Bull Case Changed?

COMPASS Pathways reported a significant net loss of US$253.79 million in Q2 2026, a sharp increase from the previous year, with losses per share at US$1.88. This surge in expenses comes as the company remains pre-revenue, intensifying focus on its ability to fund the …

Strata Critical Medical (SRTA) Stock Faces Clinical Progress And Lingering Losses

Strata Critical Medical (SRTA) reported Q2 2026 results showing significant clinical revenue growth, reaching US$72.5m, and improved adjusted EBITDA margins, signaling a successful pivot towards clinical services. Despite these operational improvements and positive free cash flow, the company continues to face losses, a short …

Segall Bryant & Hamill LLC Invests $2.29 Million in Chemed Corporation $CHE

Segall Bryant & Hamill LLC has initiated a new position in Chemed Corporation (NYSE:CHE) by purchasing 5,695 shares valued at $2.29 million. Chemed exceeded its recent quarterly earnings expectations, reporting $6.06 EPS against an estimate of $5.60 and revenue of $673.25 million, an 8.8% …

US Physical Therapy faces earnings test on hospital strategy By Investing.com

US Physical Therapy (USPH) is set to release its second-quarter results, with investors keenly watching its hospital partnership strategy's impact on profitability after a disappointing first quarter. Analysts are cautiously optimistic, expecting improved earnings and revenue, but concerns remain regarding execution on alliances, margin …

RBC Capital Adjusts Price Target on Addus HomeCare to $134 From $130, Maintains Outperform Rating

RBC Capital has increased its price target for Addus HomeCare (NASDAQ:ADUS) to $134 from $130, while reiterating an Outperform rating on the stock. This adjustment suggests a positive outlook on the company's financial performance or market position. Investors should note this change in analyst …

Independent monitor discusses HCA's ownership of Mission Hospital

Members of the independent monitor answered public questions on August 4th regarding HCA's 2019 acquisition of Mission Hospital. While a new healthcare system taking over Mission Hospital is unlikely due to HCA's obligation not to sell for 10 years, the monitor's 2025 report flagged …

Avoiding Lag: Real-Time Signals in (PACS) Movement

This article analyzes Pacs Group Inc. (NASDAQ: PACS), highlighting weak near-term sentiment but strong mid and long-term outlooks. It details three AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss zones, alongside multi-timeframe signal analysis for support and resistance levels. …

Strata Critical Medical, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:SRTA)

This article provides the slide deck published by Strata Critical Medical, Inc. (SRTA) in conjunction with their Q2 2026 earnings call. The content is presented by SA Transcripts, a team dedicated to publishing earnings call transcripts and related developments.

Investors Return to US Healthcare Stocks as Earnings and Deal Activity Drive Sector Rebound

Ardent Health, Inc. (ARDT) Releases Q2 2026 Earnings: EPS Miss and Profitability Declines

Ardent Health, Inc. (ARDT) reported Q2 2026 revenue of $1.6 billion, in line with analyst expectations, but experienced a decline in profitability with diluted EPS at $0.12, missing the $0.18 estimate. Despite the profit decline, the company saw stronger cash generation. Insider trading activity …

COMPASS PATHWAYS ($CMPS) Releases Q2 2026 Earnings

COMPASS Pathways plc Q2 2026: Revenue $0 Net loss $253.8M, EPS $(1.88) — 10-Q Summary

COMPASS Pathways plc reported a net loss of $253.8M, or diluted loss per share of $(1.88), for Q2 2026, with no product revenue as it remains a clinical-stage company. The company achieved positive primary endpoints in Phase 3 trials for treatment-resistant depression and advanced …

Compass Pathways (Nasdaq: CMPS) posts $253.8M Q2 loss and builds COMP360 launch

Compass Pathways reported a Q2 2026 net loss of $253.8 million, largely due to a non-cash loss from warrant liabilities, compared to $38.4 million in Q2 2025. Despite the widened loss, the company is making significant progress with its COMP360 psilocybin treatment for treatment-resistant …

DaVita Inc. Stock 12‑Month Price Target Raised to $230, Implies 1% Upside

Analysts have raised the 12-month average price target for DaVita Inc. (DVA) stock from $217.33 to $230, with individual forecasts ranging from $170 to $270 per share. This new target suggests a 1% potential upside based on the stock's closing price on August 4. …

Ardent Health, Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:ARDT) 2026-08-05

Ardent Health, Inc. published its Q2 2026 earnings call presentation, reporting an EPS of $0.27, beating estimates by $0.08. The company's revenue reached $1.62 billion, exceeding expectations by $32.57 million despite a 1.40% year-over-year decrease. This presentation provides details on the company's financial performance …

Strata Critical Medical, Inc. 2Q 2026: Revenue $72.51M, EPS ($0.12) — 10-Q Summary

Strata Critical Medical, Inc. reported its Q2 2026 financial results, showing revenue of $72.51 million, a 60.7% increase year-over-year, largely due to Logistics expansion and newly acquired Clinical services. The net loss widened to ($10.52M) with a diluted loss per share of ($0.12). The …

Why Ardent Health (ARDT) Is Down 6.3% After Cutting 2026 Earnings Guidance On Weaker Q2 Results

The Oncology Institute, Inc. Revenue Breakdown – NASDAQ:STLN

The Oncology Institute, Inc. (NASDAQ: STLN) generated $502.73 million in revenue last year, with its Dispensary segment being the top performer, contributing $269.18 million. The majority of its revenue, $502.73 million, originated from the United States. This indicates a strong domestic market for the …

DaVita Inc (DVA) (Q2 2026) Earnings Call Highlights: Strong Volume Growth and Strategic ...

DaVita Inc. reported strong Q2 2026 results with adjusted operating income of $579 million and EPS of $4.02, driven by higher-than-expected treatment volume growth. The company reaffirmed its full-year guidance and continued share repurchases. While facing headwinds like declining revenue per treatment due to …

Addus HomeCare (ADUS) Stock Pulls Back Despite Firm Earnings And Policy Risks

biote Corp. (BTMD) Releases Q2 2026 Earnings: Revenue Declines and EPS Miss

biote Corp. (BTMD) Reports Break-Even Earnings for Q2

agilon health turns a $104M Q2 net loss into $18M net income

Agilon (AGL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates